{"entity":{"id":"nature-medicine","kind":"journal","name":"Nature Medicine","aka":["Nat Med","src-nature-medicine"],"tldr":"Nature Medicine is Nature's clinical journal and now a top venue for early-phase and biomarker-rich cancer trials, medical AI studies and cell-therapy reports.","summary":"Nature Medicine appears monthly and publishes phase 1 and 2 trials with deep translational analysis (MagnetisMM-3 elranatamab in this corpus), circulating tumour DNA and multi-cancer early-detection studies, large medical-AI validations and consensus reporting guidelines for AI in medicine. Hybrid access with a Springer Nature open-access option.","asOf":"2026-09-09","links":[{"label":"Nature Medicine cancer","url":"https://www.nature.com/nm/research-articles?subject=cancer"}],"tags":[],"related":[],"indications":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":["Holds: Translational medicine including cancer vaccines, AI diagnostics and phase 1 to 3 trials with mechanistic depth. Access: Paywalled; abstracts free; some open access."],"publisher":"Springer Nature","url":"https://www.nature.com/nm/","issn":"1078-8956","scope":"translational medicine","access":"hybrid","founded":1995,"impactFactor":{"value":58.7,"year":2023,"source":"Clarivate Journal Citation Reports 2024 (2023 JIF)"},"matchNames":["Nature Medicine","Nat Med"]},"route":"/journals/nature-medicine/","neighbours":{}}